<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 03 May 2022 11:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration</title>
   <link>http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Curative+Biotechnology+Announces+Toxicology+Studies+Under+Good+Laboratory+Practices+%28GLP%29+for+Metformin+Eye+Drop+Formulations+for+Treatment+of+Macular+Degeneration/20007530.html</guid>
   <pubDate>Tue, 03 May 2022 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.25657929</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUBT</category>
   	  </item>
  <item>
   <title>Curative Biosciences Announces New Line of THC-Free CBD Softgels</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html</guid>
   <pubDate>Tue, 05 May 2020 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Announces New Line of THC-Free CBD Softgels</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Softgels/16833661.html</guid>
   <pubDate>Tue, 05 May 2020 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Announces New Line of THC-Free CBD Oil Tinctures</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600457.html</guid>
   <pubDate>Tue, 11 Jun 2019 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Announces New Line of THC-Free CBD Oil Tinctures</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600422.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600422.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Announces+New+Line+of+THC-Free+CBD+Oil+Tinctures/15600422.html</guid>
   <pubDate>Tue, 11 Jun 2019 10:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Prepares to Launch Line of Hemp-Derived CBD Products</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Prepares+to+Launch+Line+of+Hemp-Derived+CBD+Products/15279265.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Prepares+to+Launch+Line+of+Hemp-Derived+CBD+Products/15279265.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Prepares+to+Launch+Line+of+Hemp-Derived+CBD+Products/15279265.html</guid>
   <pubDate>Wed, 20 Mar 2019 09:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    CURATIVE BIOSCIENCES,     For: Sep 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Sep+30/14831984.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Sep+30/14831984.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Sep+30/14831984.html</guid>
   <pubDate>Wed, 14 Nov 2018 16:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Form  S-8        CURATIVE BIOSCIENCES,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CURATIVE+BIOSCIENCES%2C++++++++++++++++/14287757.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CURATIVE+BIOSCIENCES%2C++++++++++++++++/14287757.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CURATIVE+BIOSCIENCES%2C++++++++++++++++/14287757.html</guid>
   <pubDate>Fri, 08 Jun 2018 06:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Form  10-Q       CURATIVE BIOSCIENCES,     For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Mar+31/14197027.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Mar+31/14197027.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Mar+31/14197027.html</guid>
   <pubDate>Tue, 15 May 2018 15:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Form  10-K/A     CURATIVE BIOSCIENCES,     For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Jun+30/14025244.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Jun+30/14025244.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++CURATIVE+BIOSCIENCES%2C+++++For%3A+Jun+30/14025244.html</guid>
   <pubDate>Thu, 05 Apr 2018 06:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Inc. Commences Trading Under Symbol CBDX</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html</guid>
   <pubDate>Wed, 14 Mar 2018 15:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06124882</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
  <item>
   <title>Curative Biosciences Inc. Commences Trading Under Symbol CBDX</title>
   <link>http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Curative+Biosciences+Inc.+Commences+Trading+Under+Symbol+CBDX/13943973.html</guid>
   <pubDate>Wed, 14 Mar 2018 15:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06124882</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CBDX</category>
   	  </item>
 </channel>
</rss>
